Cargando…
Targeting of drugs and nanoparticles to tumors
The various types of cells that comprise the tumor mass all carry molecular markers that are not expressed or are expressed at much lower levels in normal cells. These differentially expressed molecules can be used as docking sites to concentrate drug conjugates and nanoparticles at tumors. Specific...
Autores principales: | Ruoslahti, Erkki, Bhatia, Sangeeta N., Sailor, Michael J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845077/ https://www.ncbi.nlm.nih.gov/pubmed/20231381 http://dx.doi.org/10.1083/jcb.200910104 |
Ejemplares similares
-
Nanoparticle amplification via photothermal unveiling of cryptic collagen binding sites
por: Lo, Justin H., et al.
Publicado: (2013) -
Immunogene therapy with fusogenic nanoparticles modulates macrophage response to Staphylococcus aureus
por: Kim, Byungji, et al.
Publicado: (2018) -
Molecular ZIP codes in targeted drug delivery
por: Ruoslahti, Erkki
Publicado: (2022) -
Bioresponsive Mesoporous Silica Nanoparticles for Triggered Drug Release
por: Singh, Neetu, et al.
Publicado: (2011) -
A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries
por: Mann, Aman P., et al.
Publicado: (2016)